U.S. (WIAT) — It’s being called a breakthrough for those who suffer from migraines.
A new FDA approved treatment called Emgality is the third in a class of new drugs that aim to stop the headaches before they begin.
Emgality is a once per month treatment. it binds wih a substance of the brain that may cause migraines. Officials report, there are no major side effects.
The drug costs about $575 per month. The company, Lily, is offering some sufferers their first year of doses for free.
